$FLWS

1-800-FLOWERS.COM Expects 2027 Net Revenue To Slip; Stock Down In Pre-Market

1-800-FLOWERS.COM (FLWS) expects fiscal 2027 net revenue to decline by mid-single digits but anticipates adjusted EBITDA of $10M-$15M, including $12M in extra compensation costs. Fiscal 2026 adjusted EBITDA was $2.9M, with net revenue of $1.503B. Shares fell 12.89% in pre-market trading.

Original reporting
Published Sep 10, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 1:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$FLWS
Neutral
medium confidence
Mentioned
$FLWS
Relevance
6/10
AlphAI data visualization · based on rttnews.com
Decision brief

The 30-second read

$FLWSNeutralMed
01

Why it matters

Guidance revision may affect valuation models and short‑term price action.

02

Market read

Guidance update is the primary news driver for FLWS.

03

What to watch

Potential upside from upcoming promotional campaigns not disclosed.

Relevance 6/10Novelty 7/10Timing: pre‑market

Background

FLWS is a Nasdaq‑listed retailer of flowers and gifts.

Company-level read

Ticker impact

$FLWSNeutralMedium confidence
Context

FLWS announced FY2027 net revenue will decline mid‑single‑digit and adjusted EBITDA of $10‑15M, new guidance.

Expected impact

Potential short‑term downside as investors price in revenue decline.

Evidence & confidence

Revenue decline is modest but EBITDA guidance is low; market may react negatively.

Market effects

May signal pressure on the broader e‑commerce gifting sector.

Limited to U.S. retail market.

Low global relevance.

Counterpoint

Revenue decline could be temporary; focus on cost control may improve margins.

Key entities

  • 1-800-FLOWERS.COM, Inc.

    Retailer providing the guidance.

Related articles

$FLWSMedAI 8/10

1-800-Flowers (FLWS) Bets On Discipline While Revenue Keeps Fading

1-800-Flowers (FLWS) reported a 10.8% revenue decline to $1.5B for fiscal 2026, with Q4 down 12.9% to $293.1M. Despite sales drops, inventory shrank and free cash flow improved by $55M. The company achieved $50M in cost savings early and plans more for fiscal 2027. Transactions fell 17.6% year-over-year, and adjusted EBITDA dropped to $2.9M from $29.2M.

$FLWSMedAI 8/10

FLOWERS (FLWS) Q4 2026 Earnings Call Transcript

1-800-FLOWERS.COM (FLWS) reported a 10.8% decline in fiscal 2026 revenue to $1.50 billion, with Q4 revenue down 12.9% YoY. Adjusted EBITDA fell to $2.9 million from $29.2 million. Management cited consumer spending shifts and higher costs. The company is focusing on operational efficiency, inventory reduction, and digital improvements. FY 2027 revenue guidance expects a mid-single-digit decline, with adjusted EBITDA projected at $10M-$15M.

$FLWSHighAI 8/10

FLOWERS (FLWS) Stock Is Trading Lower Today

1-800-FLOWERS (FLWS) shares dropped 13% after reporting a wider-than-expected quarterly loss, a full-year net loss of $134.8M, and weak forward guidance. Revenue fell 12.9% YoY to $293.1M, with an adjusted loss of $0.80 per share. The company projected FY2027 EBITDA of $12.5M, below analyst estimates of $20.02M.

$FLWSMed

1-800-FLOWERS.COM, Inc. Q4 2026 Earnings Call Summary

1-800-FLOWERS.COM reported achieving $50M in cost savings ahead of schedule, with fiscal 2027 revenue expected to decline in the mid-single-digit range. Adjusted EBITDA guidance is $10M-$15M, including a $12M headwind. The company plans $15M-$20M in additional cost savings and reinvestments in marketing and technology. Management also discussed potential asset divestitures and strategic shifts.

$FLWSHighAI 8/10

Why is 1-800 FLOWERS.COM stock sliding today?

1-800 FLOWERS.COM (FLWS) stock fell 8.6% to $3.19 in pre-market trading after reporting Q4 and full-year fiscal 2026 results. The company guided for a 10-12% revenue decline, with weak segment performance and near-breakeven EBITDA. Analysts had anticipated revenue and profit declines, citing ineffective cost-cutting and marketing shifts. The stock has been trading near its 52-week low.